Entos Pharmaceuticals Inc. is a clinical-stage genetic medicines company. A new reality in genetic medicine lies ahead, one that will be ushered in with the advent of safe, effective, and redosable nucleic acid delivery technologies. At Entos, we develop next generation genetic medicines using our proprietary Fusogenix proteolipid vehicle (PLV) drug delivery system. Fusogenix PLVs are formulated with FAST proteins to enable the delivery of nucleic acid into target cells through direct fusion.
Looking for a particular Entos Pharmaceuticals employee's phone or email?
The Entos Pharmaceuticals annual revenue was $18.6 million in 2026.
Arun Raturi is the CSO of Entos Pharmaceuticals.
24 people are employed at Entos Pharmaceuticals.
Entos Pharmaceuticals is based in Edmonton, Alberta.
The NAICS codes for Entos Pharmaceuticals are [5417, 325, 541711, 32, 541, 54171, 54].
The SIC codes for Entos Pharmaceuticals are [2834, 28, 283].